erlotinib hydrochloride has been researched along with Eardrum Perforation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herzog, M; Hosemann, W; Kaftan, H; Miehe, B; Reuther, L | 1 |
| Herzog, M; Hosemann, W; Kaftan, H; Lempas, K; Vogelgesang, S | 1 |
| Buchler, T; Joseph, T; Lai, C; Lee, SM | 1 |
3 other study(ies) available for erlotinib hydrochloride and Eardrum Perforation
| Article | Year |
|---|---|
The influence of inhibition of the epidermal growth factor receptor on tympanic membrane wound healing in rats.
Topics: Administration, Topical; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Disease Models, Animal; ErbB Receptors; Erlotinib Hydrochloride; Female; Male; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Inbred Lew; Tympanic Membrane; Tympanic Membrane Perforation; Wound Healing | 2010 |
Inhibition of epidermal growth factor receptor by erlotinib: wound healing of experimental tympanic membrane perforations.
Topics: Animals; Chronic Disease; ErbB Receptors; Erlotinib Hydrochloride; Protein Kinase Inhibitors; Quinazolines; Rats; Tympanic Membrane Perforation; Wound Healing | 2007 |
Bilateral eardrum perforation after long-term treatment with erlotinib.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Middle Aged; Quinazolines; Tympanic Membrane Perforation | 2008 |